Blockage of Autophagy Rescues the Dual PI3K/mTOR Inhibitor BEZ235- induced Growth Inhibition of Colorectal Cancer Cells

키워드

참고문헌 (33)

1. Blaser B, "Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells", BMC Cancer, 12, pp.86~95 (2012)
2. Chi S, "Oncogenic Ras triggers cell suicide through the activation of caspase-independent cell death program in human cancer cells", Oncogene, 18, pp.2281~2290 (1999)
3. Erlandsson F, "A detailed analysis of cyclin A accumulation at the G1", S border in normal and transformed cell, 2000, pp.259, 86~95
4. Guertin DA, "Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to AKT-FOXO and PKCalpha, but not S6K1", Dev Cell, 11, pp.859~871 (2006)
5. Guo JY, "Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis", Genes Dev, 25, pp.460~470 (2011)
6. Hung F, "Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrialdependent signaling pathways in A375.S2 human melanoma cells", Oncol Rep, 29, pp.1053~1060 (2013)
7. Joe AK, "Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines", Clin Cancer Res, 8, pp.893~903 (2002)
8. Kuger S, "Simultaneous perturbation of the PAPK and the PI3K", mTOR pathways does not lead to increased radiosensitization, 2015, pp.10, 214~229
9. Laurent-Puig P, "Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer", J Clin Oncol, 27, pp.5924~5930 (2009)
10. Lee YM, "Targeting cyclins and cyclindependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human", Cell Cycle, 5, pp.2110~2114 (2006)
11. Li H, "Inhibition of autophagy enhances apoptosis induced by the PI3K", AKT, Cell Biochem Funct, pp.2013, 31[DOI]
12. Li JR, "Dual inhibitor of phosphoinositide 3-kinase", mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux, 2013, pp.220, 267~276
13. Maira S, "Identification and characterization of NVPBEZ235, a new orally available dual phosphatidylinositol 3-kinase", mammalian target of rapamycin inhibitor with potent in vivo antitumor activity, 2008, pp.7, 1851~1863
14. Mendoza MC, "The RAS-ERK and PI3K-mTOR pathways: cross-talk and compensation", Trends Biochem Sci, 36, pp.320~327 (2011)
15. Mizushima N, "Methods in mammalian autophagy research", Cell, 140, pp.313~326 (2010)
16. Moon DG, "NVPBEZ235, a dual PI3K", mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells, 2014, pp.45, 1027~1035
17. Muise-Helmericks RC, "Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase", Akt-dependent pathway, 1998, pp.273, 29864~29872
18. 박덕배, "Biphasic Activity of Chloroquine in Human Colorectal Cancer Cells", 발생과 생식, 18(4), pp.225~231 (2014), 한국발생생물학회
19. Roper J, "The dual PI3K", mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wildtype colorectal cancer, 2011, pp.6, 1~10
20. Sarbassov DD, "Phosphorylation and regulation of AKT", PKB by the rictor-mTOR complex, 2005, pp.307, 1098~1101
21. Sasaki K, "Chloroquine potenntiates the anti-cancer effect of 5-fluorouracil on colon cancer cells", BMC Cancer, 10, pp.370~381 (2010)
22. Schult C, "The dual kinase inhibitor NVPBEZ235 in combination with cytotoxic drugs exerts antiproliferative activity towards acute lymphoblastic leukemia cells", Anticancer Res, 32, pp.463~474 (2012)
23. Seitz C, "The dual PI3K", mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial- lysosomal cross-talk, 2013, pp.132, 2682~2693
24. Shapiro GI, "Cyclin-dependent kinase pathways as targets for cancer treatment", J Clin Oncol, 24, pp.1770~1783 (2006)
25. Shigemitsu K, "Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells", J Biol Chem, 274, pp.1058~1065 (1999)
26. Ji-Hoon Song, "Mechanism of Ethanol-induced Purkinje Cell Death in Developing Rat Cerebellum: Its Implication in Apoptosis and Oxidative Damage", 발생과 생식, 15(3), pp.205~213 (2011), 한국발생생물학회
27. Sui X, "Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment", Cell Death Dis, 4, pp.e838~e849 (2013)
28. Szakacs G, "Targeting multidrug resistance in cancer", Nat Rev Drug Discov, 5, pp.219~234 (2006)
29. Takeuchi H, "Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase", protein kinase B inhibitors, 2005, pp.65, 3336~3346
30. Wolfian BM, "Systemic treatment of colorectal cancer", Gastroenterology, 134, pp.1296~1310 (2008)
31. Xu C, "Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy", Cancer Biol Ther, 12, pp.549~555 (2011)
32. Yang F, "Dual phosphoinositide 3-kinase", mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma, 2013, pp.8, e58879~e58889
33. Yang P, "Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies", Cancer Res, 70, pp.7699~7709 (2010)

관련 논문AI추천